Compare BZUN & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BZUN | MBOT |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.4M | 126.3M |
| IPO Year | N/A | N/A |
| Metric | BZUN | MBOT |
|---|---|---|
| Price | $2.71 | $2.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 202.8K | ★ 3.1M |
| Earning Date | 11-25-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,372,022,139.00 | N/A |
| Revenue This Year | $5.92 | N/A |
| Revenue Next Year | $3.80 | $2,166.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.08 | N/A |
| 52 Week Low | $2.12 | $0.93 |
| 52 Week High | $4.88 | $4.67 |
| Indicator | BZUN | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 37.59 | 42.65 |
| Support Level | $2.58 | $2.04 |
| Resistance Level | $2.76 | $2.55 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 26.04 | 8.65 |
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.